Publication | Closed Access
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
212
Citations
24
References
2015
Year
Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyPathologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1